Zimmer Biomet Holdings, Inc. ZBH

91.04 1.35 1.51% as of 25 Sep
Market cap
$17.1B
P/E
22.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Zimmer Biomet Holdings, Inc. (ZBH) P/S ratio

As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a P/S ratio of 2.1×. Over the past ten years it has ranged from 1.8× (May 2026) to 6.1× (April 2021); the current reading is higher than 2% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 2.2× (22.58%)
FY2024 2.8× (18.45%)
FY2023 3.4× (10.87%)
FY2022 3.8× 2.01%
FY2021 3.8× (25.43%)
FY2020 5.1× 35.35%
FY2019 3.7× 44.55%
FY2018 2.6× (17.11%)
FY2017 3.1× 19.11%
FY2016 2.6× (15.92%)

Quarterly

Period P/S ratio Change
Jun 2026 1.9× (7.26%)
Mar 2026 2.1× (3.06%)
Dec 2025 2.2× (11.20%)
Sep 2025 2.4× 5.71%
42 more quarters

Against its own ten years

Low 1.8× High 6.1×
Ten-year median 3.2×
Current reading's percentile 2

P/S ratio against peers

Company P/S ratio
SNN Smith & Nephew SNATS, Inc. compare 1.2×
PHG Koninklijke Philips N.V. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.4×
ZBH Zimmer Biomet Holdings, Inc. 2.1×
GMED Globus Medical, Inc. compare 3.2×
STE STERIS plc compare 3.4×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
BIO Bio-Rad Laboratories, Inc. compare 3.9×
PEN Penumbra, Inc. compare 8.3×
Medical Devices industry median 2.7×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on ZBH